Medical Research

Episodes 1-5 of 5

• 

  RestartResume

  Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

  RestartResume

  Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

  AudioAbstracts

  Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

• 

  RestartResume

  The Crohn's & Colitis Foundation's New Clinical Trial Community

  RestartResume

  The Crohn's & Colitis Foundation's New Clinical Trial Community

  Crohn’s & Colitis Foundation Perspectives

  The Crohn's & Colitis Foundation's New Clinical Trial Community

• 

  RestartResume

  Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

  RestartResume

  Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

  AudioAbstracts

  Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

• 

  RestartResume

  Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study

  RestartResume

  Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study

  AudioAbstracts

  Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study

• 

  RestartResume

  Clinical Trials in IBD: Advancing Science, Enhancing Patient Care

  RestartResume

  Clinical Trials in IBD: Advancing Science, Enhancing Patient Care

  Crohn’s & Colitis Foundation Perspectives

  Clinical Trials in IBD: Advancing Science, Enhancing Patient Care

  • 

    

    Caren Heller, MD

  • 

    

    William J. Sandborn, MD